INTRODUCTION
Atrial fibrillation (AF) is the most common cardiac arrhythmia, accounting for one-third of the rhythm disturbances, and is associated with substantial morbidity and mortality [1] .
AF is related to systemic or pulmonary thromboembolism due to a slow and stagnant blood flow in the atria. The risk of stroke associated with AF is 5% to 8% per year, and AF is associated with a five-to seven-fold increase in the overall risk of stroke [1] [2] [3] .
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In recent years, the management of AF has rapidly evolved, with many available options to achieve either rate or rhythm control [4, 5] . The traditional goals of treatment were to control the ventricular response rate by using pharmacological agents and to prevent thromboembolic events.
However, medical treatments have limited efficacy in maintaining the sinus rhythm and may exhibit serious adverse effects [6] [7] [8] .
Since the Cox maze procedure was first introduced in 1987, it has been considered the gold standard for the surgical treatment of AF. After the late 1990s, by means of various energy sources, the procedure was modified into the Cox maze IV procedure, which is less invasive and uses various energy sources to shorten the procedure time [9] . In our previous study, it was reported that the Cox maze IV procedure using N2O-based cryoablation and bipolar radiofrequency is safe and comparable to various other maze procedures [10] .
In our institution, we use an argon-based cryoprobe as well as an N2O-based cryoprobe. The advantage of argon-based cryoablation over N2O-based cryoablation is that the argon-based technique can reach a temperature of -140 o C to -160 o C compared with -60 o C for N2O, allowing for a faster and more reliable ablation lesion [11] . In this study, we compared the mid-term results of the Cox maze IV procedure using argon-based cryoablation with the same procedure using N2O-based cryoablation. 
METHODS

RESULTS
1) Comparisons of the patients' characteristics and operative data of the two groups
The etiologies of valvular heart disease included 91 rheumatic (65.9%), 30 degenerative (21.7%), and 17 other etiologies (12.3%), such as the mixed form or congenital causes.
One hundred and thirty five patients exhibited longstanding persistent AF, and three patients exhibited paroxysmal AF.
There were no differences in the baseline characteristics, echocardiographic parameters, or characteristics of AF between two groups except that patients in group N were older than those in group A (61.2±11.3 years and 56.4±10.4 years, respectively; p=0.011) ( Table 1) .
Mitral valve procedures were performed more frequently in group N than in group A (80 patients versus 43 patients, respectively; p=0.017). Other cardiac procedures included aortic valve operations (n=43, 31.1%), tricuspid valve surgery Cox Maze IV Procedure Using Argon-Based Cryoablation Values are presented as mean±standard deviation or number (%).
(n=117, 84.8%), ascending aorta procedures (n=13, 9.4%), and coronary artery bypass grafting (n=7, 5.1%). There were two redo open heart surgery cases, both of which belonged to group A. The maze lesion sets were standardized for all patients, as described in our previous report [10] , with the exception of the energy sources for ablation. Bipolar radiofrequency ablation was concomitantly used in 131 patients (Table 2) .
2) Early clinical results
Early mortality occurred in 6 patients (4.3%). Postoperative morbidities included low cardiac output syndrome (n=7, 5.1%), postoperative bleeding (n=3, 2.2%), acute renal failure (n=2, 1.4%), stroke (n=4, 2.9%), and thromboembolic event (n=1, 0.7%). There were no differences in early mortality or postoperative complications between the two groups (Table   3 ). Values are presented as number (%). Multivariate analysis revealed that the fine F wave (＜0.1 mV) was the only significant risk factor predicting the presence of AF after 1 year (p＜0.001, odds ratio=20.287). The energy source of cryoablation was not associated with the presence of AF after 1 year (p=0.862) ( Table 5 ).
3) Rhythm status and risk factors for maze failure
DISCUSSION
The original Cox maze procedure was introduced in 1987 as a cut-and-sew method [12, 13] . Since then, the time-consuming and technically challenging cut-and-sew lesions have been replaced by the application of alternative energy sources.
In 1999, the first non-cut-and-sew full Cox maze procedure was performed using cryothermal energy as the only ablation modality, and the Cox maze III procedure was modified into the Cox maze IV procedure, which is less invasive and requires less procedure time. In this procedure, the pulmonary veins are isolated bilaterally, and a connecting lesion is applied rather than performing the original box lesion [9] . This modification was based on the findings published in the work of Haissaguerre and his colleagues [14] .
Various ablation devices have been developed using different energy sources to perform the ablation, including radiofrequency (unipolar and bipolar), microwave, laser, cryoablation, and high-frequency ultrasound [9] . With all the available energy sources, the major issue remains the reliable creation of a transmural lesion. Disagreement exists with respect to the optimal energy sources used in creating the transmural lesion with the efficacy of the cut-and-sew Cox maze III procedure [15, 16] . However, experimental data demonstrate that produces a transmural lesion [3] . In our previous report, we demonstrated that the Cox maze IV procedure using N2O-based cryoablation and bipolar radiofrequency was a safe and effective method to terminate AF [10] . er the cryoablation segment [11, 17] . In the present study, however, the aortic cross-clamp and cardiopulmonary bypass times were not shorter in group A than those in group N despite the advantages of argon-based cryoablation over N2O-based cryoablation. This might be due to the differences in operative characteristics such as more cases of redo open heart surgery and combined aortic operation, and less frequent use of RF ablation in group A patients than in group N patients.
Some investigators have reported the results of argon-based cryoablation for the AF treatment during a concomitant cardiac operation. In these reports, 81% to 89% of the patients were free from AF at 12 months, and 70% to 71% of the patients were free from AF at 24 months [17, 18] . Although there were some differences in the technique and ablation lesion set, we achieved similar results in group A, with freedom from AF in 85.7% and 70.6% of the patients after 12 months and 2 years, respectively. These results were similar to those of the maze procedure using N2O-based cryoablation.
Our data confirmed that argon-based cryoablation was as effective as N2O-based cryoablation, which has been widely used with proven safety and efficacy. Considering the advantages of argon-based cryoablation described above, our data support the use of the Cox maze IV procedure with argon-based cryoablation in patients with AF.
Risk factors for the failure of maze procedures include oldKyung-Hak Lee, et al − 372 − er age, larger left atrial size, and the presence of preoperative tricuspid regurgitation [9, 10] . This analysis also observed that older age, larger left atrial size, and preoperative more than moderate tricuspid regurgitation were significant risk factors for the failure of maze procedures in the univariate analysis but not in the multivariate analysis. In the multivariate analysis, the fine F wave (＜0.1 mV) was the only significant risk factor predicting the presence of AF after 1 year.
The limitations of this study are as follows. First, the present study was designed as a retrospective study. Second, the patients' rhythm status was evaluated using only a 12-lead ECG at each time period. Third, the number of patients was relatively small to draw definite conclusions.
In conclusion, the Cox maze IV procedure using an argon-based cryoprobe is safe and effective compared with the maze procedure using an N2O-based cryoprobe in terms of the operative outcomes and the restoration of the sinus rhythm for up to 2 years after surgery.
